The Heat Map shows these symbols by color. Each symbol can be clicked to scroll to the symbol details.
Below is a clickable Heat Map of the 1 symbols on this page. The percent change is based on Wednesday's prices. Each symbol is a hyperlink or shortcut to more information.INCY 1.09%
Market Cap 19 Billion
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant, which Eli Lilly licenses, and oncology drug Iclusig for chronic myeloid leukemia. Incyte's pipeline includes a broad array of oncology and autoimmune programs, including next-generation JAK inhibitor itacitinib.
EPS 0.60 P/E Ratio 145.02
Previous Tue, Jul 30, 2019
Latest Tue, Oct 29, 2019 (22 days ago) Price +11.32%
Pay Date --
Dec 24, 2018
|Symbol||Price||Day Δ||YTD Δ|
How can we make Symbol Surfing better?
©2019 Symbol Surfing All Rights Reserved.
Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.